Impax Laboratories (IPXL)

Add to Watchlists
Create an Alert
23.92 -0.39  -1.60% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
IPXL Price Chart
View All Events

IPXL Events

Date Type Description
May 01 Misc Impax Laboratories, Inc. Q1 2014 Earnings Conference Call
May 01 Earnings Impax Laboratories, Inc. Q1 2014 Earnings Results. Estimate: 0.12.
Feb 20 Misc Impax Laboratories Conference Call and Webcast for Fourth Quarter and Full Year 2013 Financial Results
Feb 20 Earnings Impax Laboratories Fourth Quarter and Full Year 2013 Financial Results. Estimate: 0.06.
Nov 04 Misc Impax Laboratories Schedules Conference Call and Webcast for Third Quarter 2013 Financial Results
Nov 04 Earnings Impax Laboratories, Inc. 2013 Third Quarter Earnings Results. Estimate: -0.07.
Aug 08 Misc Impax Laboratories Schedules Conference Call and Webcast for Second Quarter 2013
Aug 08 Earnings Impax Laboratories Schedules Conference Call and Webcast for Second Quarter 2013 Financial Results. Estimate: 0.02.
May 14 Misc AGM Event for Impax Laboratories, Inc.
May 01 Misc Impax Laboratories Schedules Conference Call and Webcast for First Quarter 2013 Financial Results
View All Performance Charts

IPXL Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Impax Laboratories is up 48.11% over the last year vs S&P 500 Total Return up 22.72%, Actavis up 102.0%, and Mallinckrodt up N/A.

Get Quote for

PDF Report for IPXL

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download IPXL Pro Report PDF
Advertisement

Portfolio Strategies Featuring IPXL

Did Impax Laboratories make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

IPXL Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: December 31, 2013
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

IMPAX Laboratories, Inc. is a technology-based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of branded products. Impax markets its generic products through its Global Pharmaceuticals division and markets its branded products through the Impax Pharmaceuticals division. Additionally, where strategically appropriate, Impax has developed marketing partnerships to fully leverage its technology platform. Impax is headquartered in Hayward, California, and has a full range of capabilities in its Hayward, Philadelphia and Taiwan facilities. It was founded by Larry Hsu in 1995.

Recent Quotes

Symbol Price Chg Chg % Market Cap
IPXL 23.92 -0.39 -1.60% 1.667B
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.